Skip to main content
Log in

Der Lymphozyt bei der chronischen lymphatischen Leukämie

  • Leitartikel
  • Published:
Blut Aims and scope Submit manuscript

Zusammenfassung

Die Mehrzahl der Blutlymphozyten von Patienten mit chronischer lymphatischer Leukämie (CLL) wies Oberflächencharakteristika von B-Zellen auf. Ultrastrukturell fand sich eine Verminderung der Zytoplasmafläche sowie der Lysosomenzahl, der ein Mangel an lysosomalen Hydrolasen entsprach. Mit zunehmender Blutlymphozytenzahl stieg der Prozentsatz lysosomenarmer Zellen an. Nach Inkubation mit PHA und PWM in vitro ließen die CLL-Lymphozyten keine oder eine verminderte und/oder verzögert eintretende Aktivierung erkennen. Dementsprechend war die Zahl transformierter Zellen reduziert. Somit dürfte es sich bei der Hauptmasse der CLL-Lymphozyten um morphologisch und funktionell abnorme, neoplastische B-Zellen handeln. Die auf die Phytomitogene reagierenden Lymphozyten zeigten wie entsprechende normale Zellen Früh-und Spätveränderungen des lysosomalen Apparates. Die aktivierbaren Lymphozyten könnten Restpopulationen funktionstüchtiger T-und/oder B-Zellen entstammen. Zusätzlich ist eine Reaktionsfähigkeit neoplastischer Zellen zu diskutieren. Bei in vivo-Untersuchungen fand sich eine gestörte Zirkulations-und Rezirkulationskinetik der den B-Zellen zuzuordnenden CLL-Blutlymphozyten, während sich die T-Zellen in dieser Hinsicht normal verhielten.

Summary

In patients with chronic lymphatic leukemia (CLL) the majority of peripheral blood lymphocytes was characterized as B cells by surface membrane markers. Ultrastructural studies revealed a reduction of the cytoplasmic area. Furthermore, the number of lysosomes was diminished corresponding to a decreased activity of lysosomal hydrolases. Increasing blood lymphocytosis was paralleled by an increase of the percentage of lysosome-poor lymphocytes. Response of CLL lymphocytes to in vitro stimulation with PHA and PWM was either lacking or diminished and/or delayed, and the number of transformed cells was reduced. Thus, the majority of CLL lymphocytes appears to represent both morphologically and functionally abnormal neoplastic B cells. During the early and later phase of stimulation the mitogen-reactive CLL lymphocytes exhibited alterations of the lysosomal apparatus similar to those observed in normal cells. The reactive lymphocytes may be derived from residual populations of normally functioning T and/or B cells. However, the neoplastic cells may also be able to respond to the mitogens. In vivo studies showed impaired kinetics of circulation and recirculation of CLL B lymphocytes, whereas the T cells were normal in this respect.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Literatur

  1. Abell C. W., Kamp C. W. & Johnson L. D.: Effects of phytohemagglutinin and isoproterenol on DNA synthesis in lymphocytes from normal donors and patients with chronic lymphocytic leukemia. Cancer Res.30, 717 (1970).

    Google Scholar 

  2. Aisenberg A. C. & Bloch K. J.: Immunoglobulins on the surface of neoplastic lymphocytes. New Engl. J. Med.287, 272 (1972).

    Google Scholar 

  3. Aiuti F., Lacava V., Fiorilli M., & Ciarla M. V.: Lymphocyte surface markers in lymphoproliferative disorders. Acta haemat. (Basel)50, 275 (1973).

    Google Scholar 

  4. Augener W., Cohnen G. & Brittinger G.: Binding of aggregated IgG by lymphocytes in chronic lymphocytic leukemia. Biomedicine Express21, 6 (1974).

    Google Scholar 

  5. Baxley G., Bishop G. B., Cooper A. G. & Wortis H. H.: Rosetting of human red blood cells to thymocytes and thymusderived cells. Clin. exp.Immunol.15, 385 (1973).

    Google Scholar 

  6. Bentwich Z., Douglas S. D., Siegal F. P. & Kunkel H. G.: Human lymphocyte-sheep erythrocyte rosette formation: Some characteristics of the interaction. Clin. Immunol. Immunopath.1, 511 (1973).

    Google Scholar 

  7. Bouroncle B. A., Clausen K. P. & Aschenbrand J. F.: Studies on the delayed response of phytohemagglutinin (PHA) stimulated lymphocytes in 25 chronic lymphatic leukemia patients before and during therapy. Blood34, 166 (1969).

    Google Scholar 

  8. Bremer K., Schick P., Wack O., Theml H., Brass B. & Heimpel H.: Rezirkulation von Lymphozyten bei Patienten mit malignen lymphatischen Systemerkrankungen. Blut24, 215 (1972).

    Google Scholar 

  9. Bremer K., Wack O. & Schick P.: Impaired recirculation of autotransfused blood lymphocytes via thoracic duct lymph in patients with chronic lymphoid leukemia. Biomedicine18, 393 (1973).

    Google Scholar 

  10. Bremer K., Fliedner T. M. & Schick P.: Kinetic differences of autotransfused, H3-cytidine labeled blood lymphocytes in leukemic and non-leukemic lymphoma patients. Europ. J. Cancer9, 113 (1973).

    Google Scholar 

  11. Bremer K., Cohnen G., Augener W. & Brittinger G.: Chronic lymphocytic leukemia: Evidence for normal recirculation of T cells (In Vorbereitung.)

  12. Brittinger G., König E., Cohnen G. & Aberle H. G.: Lysosomale Enzyme in Lymphozyten. I. Lymphoretikuläre Erkrankungen: Vergleich des Enzymgehaltes (saure Phosphatse, \-Glucuronidase) unstimulierter Blutlymphozyten mit der Blastentransformation nach Phytohämagglutinin-Stimulierung in vitro. Acta haemat. (Basel)44, 205 (1970).

    Google Scholar 

  13. Brody J. I., Oski F. A. & Singer D. E.: Impaired pentose phosphate shunt and decreased glycolytic activity in lymphocytes of chronic lymphocytic leukemia. Metabolic pathway? Blood34, 421 (1969).

    Google Scholar 

  14. Brown G., Greaves M. F., Lister T. A., Rapson N. & Papamichail M.: Expression of human T and B lymphocyte cell-surface markers on leukaemic cells. Lancet1974/II, 753.

  15. Catovsky D., Miliani E., Okos A. & Galton D. A. G.: Clinical significance of T-cells in chronic lymphocytic leukaemia. Lancet1974/II, 751.

  16. Cohnen G., Douglas S. D., König E. & Brittinger G.: Acid phosphatase cytochemistry of mitogen-transformed normal and chronic lymphocytic leukemia lymphocytes. Exp. Cell Res.80, 297 (1973).

    Google Scholar 

  17. Cohnen G., Augener W., Buka A. & Brittinger G.: Rosetteforming lymphocytes in normals and patients with malignant lymphomas. Acta haemat. (Basel)51, 65 (1974).

    Google Scholar 

  18. Cohnen G.: T-und B-Lymphozyten bei chronischer lymphatischer Leukämie und Lymphogranulomatose. Elektronenmikroskopische und immunologische Untersuchungen. In: Veröffentlichungen aus der Pathologie, Heft 97, Gustav Fischer Verlag, Stuttgart 1975.

    Google Scholar 

  19. Dickler H. B., Siegal F. P., Bentwich Z. H. & Kunkel H. G.: Lymphocyte binding of aggregated IgG and surface Ig staining in chronic lymphocytic leukaemia. Clin. exp. Immunol.14, 97 (1973).

    Google Scholar 

  20. Douglas S. D.: Electron microscopic and functional aspects of human lymphocyte response to mitogens. Transplant. Rev.11, 39 (1972).

    Google Scholar 

  21. Douglas S. D., Cohnen G., König E. & Brittinger G.: Lymphocyte lysosomes and lysosomal enzymes in chronic lymphocytic leukemia. Blood41, 511 (1973).

    Google Scholar 

  22. Engeset A., Fröland S. S. & Bremer K.: Studies of human peripheral lymph. II. Low lymphocyte count and few B-lymphocytes in peripheral lymph of patients with chronic lymphocytic leukemia. Scand. J. Haemat.13, 93 (1974).

    Google Scholar 

  23. Flad H. D., Huber Ch., Bremer K., Menne H. D. & Huber H.: Impaired recirculation of B-lymphocytes in chronic lymphocytic leukemia. Europ. J. Immunol.3, 688 (1973).

    Google Scholar 

  24. Fröland S. S., Natvig J. B., & Stavem P.: Immunological characterization of lymphocytes in lymphoproliferative diseases. Restriction of classes, subclasses, and Gm allotypes of membrane-bound Ig. Scand. J. Immunol.1, 351 (1972).

    Google Scholar 

  25. Fu S. M. & Kunkel H. G.: Membrane immunoglobulins of B lymphocytes. Inability to detect certain characteristic IgM and IgD antigens. J. exp. Med.140, 895 (1974).

    Google Scholar 

  26. Grey H. M., Rabellino E. & Pirofsky B.: Immunoglobulins on the surface of lymphocytes. IV. Distribution in hypogammaglobulinemia, cellular immune deficiency, and chronic lymphatic leukemia. J. clin. Invest.50, 2368 (1971).

    Google Scholar 

  27. Hirschhorn R., Brittinger G., Hirschhorn K. & Weissmann G.: Studies on lysosomes. XII. Redistribution of acid hydrolases in human lymphocytes stimulated by phytohemagglutinin. J. Cell Biol.37, 412 (1968).

    Google Scholar 

  28. Holt P. J. L., Pal S. G., Catovsky D. & Lewis S. M.: Surface structure of normal and leukaemic lymphocytes. I. Effects of mitogens. Clin. exp. Immunol.10, 555 (1972).

    Google Scholar 

  29. Huang A. T., Kremer W. B., Laszlo J. & Setlow R. B.: DNA repair in human leukaemic lymphocytes. Nature (New Biol.)240, 114 (1972).

    Google Scholar 

  30. Huber Ch., Michlmayr G. & Huber H.: Immunologische Marker in der Differentialdiagnose lymphatischer Systemerkrankungen. Dtsch. med. Wschr.99, 2262 (1974).

    Google Scholar 

  31. Huber Ch., Michlmayr G., Braunsteiner H. & Huber H.: Redistribution of immunoglobulin determinants on human lymphocytes in lymphoproliferative disorders. Europ. J. Cancer10, 517 (1974).

    Google Scholar 

  32. Klein E., Eskeland T., Inoue M., Strom R. & Johansson B.: Surface immunoglobulin-moieties on lymphoid cells. Exp. Cell Res.62, 133 (1970).

    Google Scholar 

  33. König, E., Cohnen G., Brittinger G. & Douglas S. D.: Response to phytohaemagglutinin and pokeweed mitogen in chronic lymphocytic leukaemia. Lancet1972/I, 795.

  34. König E., Brittinger G. & Cohnen G.: Relation of lysosomal fragility in CLL lymphocytes to PHA reactivity. Nature (New Biol.)244 247 (1973).

    Google Scholar 

  35. König E.: Lysosomen und lysosomale Enzyme in Blutlymphozyten von Patienten mit chronischer lymphatischer Leukämie (CLL) vor und nach Phytomitogen-Stimulierung in vitro. Habilit.schrift, Essen 1974.

  36. Kornfeld S.: Decreased phytohemagglutinin receptor sites in chronic lymphocytic leukemia. Biochim. Biophys. Acta192, 542 (1969).

    Google Scholar 

  37. Kubo R. T., Grey H. M. & Pirofsky B.: IgD: A major immunoglobulin on the surface of lymphocytes from patients with chronic lymphatic leukemia. J. Immunol.12, 1952 (1974).

    Google Scholar 

  38. Lopez J., Zucker-Franklin D. & Silber R.: Heterogeneity of 5′-nucleotidase activity in lymphocytes in chronic lymphocytic leukemia. J. clin. Invest.52, 1297 (1973).

    Google Scholar 

  39. Menne H.-D. & Flad H.-D.: Membrane dynamics of HL-A-anti-HL-A complexes of human normal and leukaemic lymphocytes. Clin. exp. Immunol.14, 57 (1973).

    Google Scholar 

  40. Novogrodsky A., Biniaminov M., Ramot B. & Katchalski E.: Binding of concanavalin A to rat, normal human, and chronic lymphatic leukemia lymphocytes. Blood40, 311 (1972).

    Google Scholar 

  41. Oppenheim J. J., Whang J. & Frei III E.: Immunologic and cytogenetic studies of chronic lymphocytic leukemic cells. Blood26, 121 (1965).

    Google Scholar 

  42. Papamichail M., Brown J. C. & Holborow E. J.: Immunoglobulins on the surface of human lymphocytes. Lancet1971/II, 850.

  43. Perera D. J. B. & Pegrum G. D.: In vitro stimulation of chronic lymphocytic leukaemic lymphocytes. Brit. J. Haemat.27, 289 (1974).

    Google Scholar 

  44. Pernis B., Forni L. & Amante L.: Immunoglobulins as cell receptors. Ann. N. Y. Acad. Sci.190, 420 (1971).

    Google Scholar 

  45. Preud'homme J. L. & Seligmann M.: Surface bound immunoglobulins as a cell marker in human lymphoproliferative diseases. Blood40, 777 (1972).

    Google Scholar 

  46. Ramsey R. L. & Ultmann J. E.: Protein synthesis by ribosomes from blood lymphocytes of normals and patients with chronic lymphocytic leukemia (CLL). Proc. Soc. exp. Biol. Med.141, 839 (1972).

    Google Scholar 

  47. Ross G. D., Rabellino E. M., Polley M. J. & Grey H. M.: Combined studies of complement receptor and surface immunoglobulin-bearing cells and sheep erythrocyte rosette-forming cells in normal and leukemic human lymphocytes. J. clin. Invest.52, 377 (1973).

    Google Scholar 

  48. Scharff M. D. & Uhr J. W.: Immunologic deficiency disorders associated with lymphoproliferative diseases. Sem. Hemat.2, 47 (1965).

    Google Scholar 

  49. Seeber S. & Schmidt C. G.: Makromolekulare Besonderheiten des Lymphozyten der chronisch-lymphatischen Leukämie (CLL). Klin. Wschr.52, 1093 (1974).

    Google Scholar 

  50. Smith J. L., Cowling D. C. & Barker C. R.: Response of lymphocytes in chronic lymphocytic leukaemia to plant mitogens. Lancet1972/I, 229.

  51. Smith J. L., Cawley J. C. & Barker C. R.: The response to plant mitogens of two subpopulations of lymphocytes in a case of chronic lymphocytic leukaemia. Clin. exp. Immunol.14, 397 (1973).

    Google Scholar 

  52. Theml H., Trepel F., Schick P., Kaboth W. & Begemann H.: Kinetics of lymphocytes in chronic lymphocytic leukemia: Studies using continous3H-thymidine infusion in two patients. Blood42, 623 (1973).

    Google Scholar 

  53. Wilson J. D. & Nossal G. J. V.: Identification of human T and B lymphocytes in normal peripheral blood and in chronic lymphocytic leukaemia. Lancet1971/II, 788.

  54. Wybran J., Chanter S. & Fudenberg H. H.: Isolation of normal T cells in chronic lymphatic leukaemia. Lancet1973/I, 126.

Download references

Author information

Authors and Affiliations

Authors

Additional information

Herrn Prof. Dr. O. H.Arnold zum 65. Geburtstag gewidmet.

Die Untersuchungen wurden mit Unterstützung durch das Landesamt für Forschung beim Minister für Wissenschaft und Forschung des Landes Nordrhein-Westfalen und die Deutsche Forschungsgemeinschaft durchgeführt.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Brittinger, G., Augener, W., Bremer, K. et al. Der Lymphozyt bei der chronischen lymphatischen Leukämie. Blut 30, 293–308 (1975). https://doi.org/10.1007/BF01633649

Download citation

  • Received:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01633649

Navigation